Adrian Duncan

Views & Analysis

As the world of medicine continues to deal with the impact of the COVID-19 pandemic, clinicians are moving to digital solutions.

News

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.